C

Catalys Pacific, LLC Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Catalys Pacific, LLC with $351.4M in long positions as of Q3 2025, 100% allocated to Healthcare, and 100% concentrated in top 10 positions.

Portfolio Value
$351.4M
Top 10 Concentration
100%
Top Sector
Healthcare (100%)
US Exposure
100%
Market Cap Focus
Mid Cap
Countries
1

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 100.00%Healthcare
Healthcare
100.00%

Industry Breakdown

1 industry across all sectors

Biotechnology: 100.00%Biotechnology
Biotechnology
Healthcare
100.00%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mid Cap ($2B - $10B): 96.09%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 3.91%
Mid Cap ($2B - $10B)
96.09%
Small Cap ($300M - $2B)
3.91%

Portfolio Concentration

Top 10 Holdings %
100.0%
Top 20 Holdings %
100.0%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
100.0%
International
-
Countries
1
United States of America
100.00% ($351.4M)
2 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
7 quarters
Avg. Top 20
7 quarters
Avg. All Positions
7 quarters
Median Holding Period
7 quarters
Persistence Rate
100.0%
Persistent Holdings Weight
100.0%
Persistent Positions
2
Longest Held
Phathom Pharmaceuticals, Inc. Common Stock logo
Phathom Pharmaceuticals, Inc. Common StockPHAT - 7 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
0.000%
Avg. Position Weight
50.00%
Largest Position
Mineralys Therapeutics, Inc. Common Stock logo
Mineralys Therapeutics, Inc. Common StockMLYS - 96.09%
Largest Ownership Stake
Mineralys Therapeutics, Inc. Common Stock logo
Mineralys Therapeutics, Inc. Common StockMLYS - 11.48%
Avg. Ownership Stake
11.09%
Ownership Stake >5%
1
Ownership Stake >1%
2

Historical (Since Q4 2023)

Avg. New Position
33.33%
Avg. Ownership Stake
13.79%
Largest Position
Mineralys Therapeutics, Inc. Common Stock logo
Mineralys Therapeutics, Inc. Common StockMLYS - 96.09% (Q3 2025)
Largest Ownership Stake
Mineralys Therapeutics, Inc. Common Stock logo
Mineralys Therapeutics, Inc. Common StockMLYS - 22.37% (Q4 2023)

Portfolio Turnover

Current Quarter

Turnover Ratio
0.0%
Value Traded
$0.00
Positions Added
0
Positions Exited
0

Historical (Since Q4 2023)

Avg. Turnover Ratio
7.3%
Avg. Positions Added
0
Avg. Positions Exited
0
Highest Turnover
50.0%
Q4 2023

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.